Skip to main content
Medicines, medical devices

Guidance and regulation

Skip to results
400 results sorted by Most viewed
  • How to write clear and effective field safety notices (FSNs) for medical devices.

  • Keep up to date with the latest information from the UK GLP monitoring authority.

  • How to change the ownership from one marketing authorisation (MA) holder to another.

  • Information about how the MHRA regulates medical devices in Northern Ireland and what legislation applies to manufacturers and suppliers.

  • A digital platform designed to facilitate the reporting, monitoring, and management of medical device incidents.

  • Information on comparator products used in studies supporting abridged marketing authorisation application.

  • Consumer advice and details of how to report problems with e-cigarettes with guidance on how to place an e-cigarette on the market in Great Britain and Northern Ireland, including the notification scheme.

  • How to use the procedure for medicines licensing applications.

  • How to make a payment by credit or debit card or a bank transfer for all applications except Device Registration and Certificates of Free Sale applications.

  • Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.

  • Guidance on out of specification investigations, including definitions and laboratory analysis and phase I,II and III investigations.

  • How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.

  • This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP)

  • A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

  • Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.

  • Documentation to support changes made to reporting Manufacturer Incident Reports (MIRs) and Field Safety Corrective Action Reports (FSCAs) to the MHRA following implementation of the Medical Devices (Post-market Surveillance…

  • Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.

  • Clinical trial applications that need expert advice from a specialist group or committee.

  • This document provides guidance on the data integrity expectations that should be considered by organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA.

  • How we regulate in vitro diagnostic medical devices (IVDs) that are placed on the UK market.